DIN 02449498 — GENVOYA 150 MG; 150 MG; 200 MG; 10 MG
GENVOYA is a tablet of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide marketed by GILEAD SCIENCES CANADA INC. The full Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02449498
- Brand name
- GENVOYA
- Active ingredient
- Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide
- Strength
- 150 MG; 150 MG; 200 MG; 10 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antiretroviral agent - fixed-dose combination integrase inhibitor with a pharmacokinetic enhancer and two nucleos(t)ide reverse transcriptase inhibitors
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.